Suspension of trading
Oncternal Therapeutics, Inc. Share Price
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Delayed
Nasdaq
02:30:00 03/12/2024 am IST
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/25/01 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/25/01 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 15.59L 13.42L 12.6L 11.5L 21.61L 15Cr 21.76L 1.49Cr 58.09L 7.52Cr 58.52L 57.25L 25Cr | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -3.24Cr -2.79Cr -2.62Cr -2.39Cr -4.49Cr -308.08Cr -4.52Cr -31Cr -12Cr -156.22Cr -12Cr -12Cr -517.27Cr | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 01/04/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 01/12/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 07/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 01/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -91.30% | 15.59L | |
| -1.23% | -1.91% | +0.98% | +17.94% | 5.05TCr | |
| -1.92% | -3.82% | +414.77% | +499.03% | 4.46TCr | |
| -0.47% | +0.01% | +41.65% | +16.90% | 4.31TCr | |
| -2.43% | -3.92% | +7.64% | +72.20% | 4.17TCr | |
| -0.94% | -1.77% | +18.34% | +46.84% | 3.32TCr | |
| -1.64% | -4.93% | +24.54% | +118.11% | 1.68TCr | |
| +6.62% | +4.39% | - | - | 1.63TCr | |
| +0.25% | -0.98% | +11.63% | +27.62% | 1.46TCr | |
| -1.87% | -4.00% | +77.76% | +38.59% | 1.39TCr | |
| Average | -2.75% | -3.70% | +66.37% | +82.88% | 2.75TCr | |
| Weighted average by Cap. | -0.85% | -1.05% | +88.72% | +121.40% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 14.9L 12.83L 12.05L 11L 20.66L 14Cr 20.8L 1.43Cr 55.54L 7.19Cr 55.95L 54.73L 24Cr | 8L 7L 6L 6L 10.88L 7.47Cr 10.96L 75.2L 29.26L 3.79Cr 29.47L 28.83L 13Cr |
| Net income | -4.42Cr -3.8Cr -3.57Cr -3.26Cr -6.12Cr -420.27Cr -6.17Cr -42Cr -16Cr -213.11Cr -17Cr -16Cr -705.65Cr | -3.95Cr -3.4Cr -3.19Cr -2.91Cr -5.47Cr -375.64Cr -5.51Cr -38Cr -15Cr -190.48Cr -15Cr -15Cr -630.7Cr |
| Net Debt | -6.36Cr -5.48Cr -5.14Cr -4.7Cr -8.82Cr -605.5Cr -8.89Cr -61Cr -24Cr -307.04Cr -24Cr -23Cr -1.02TCr | -3.39Cr -2.92Cr -2.74Cr -2.5Cr -4.7Cr -322.91Cr -4.74Cr -33Cr -13Cr -163.74Cr -13Cr -12Cr -542.17Cr |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
